Active Folate and Vitamin K2 Seminar
The “Active Folate and Vitamin K2 Seminar” on 14th July 2022 is a jointly organized congress between Gnosis by Lesaffre and key partner Samoh Pharm to discuss the science and discoveries behind Quatrefolic® and MenaQ7®.
Held at the Coex Convention & Exhibition Center, the “Active Folate and Vitamin K2 Seminar” will greet more than 100 professionals from over 40 companies at this event. With a collective ambition to improve living, Gnosis by Lesaffre and Samoh Pharm aims to bring to the public, a better understanding, and commercial opportunities of Quatrefolic®, an active folate (vitamin B9) and Vitamin K2, namely MenaQ7®. There is a keen interest from the market on this innovative folate and Vitamin K2 which is anticipated to be monographed later this year.
Acclaimed for her knowledge and expertise on the folate and women’s health market, Silvia Pisoni, Global Market Manager of Gnosis by Lesaffre, will share on Quatrefolic® mechanism of action – with specific focus on the differences among the other folate forms, health applications and market trends. She will provide an extensive description of the exclusive benefits of this active folate patented and produced exclusively by Gnosis by Lesaffre.
The second half of the meeting will focus on Vitamin K2, menaquinone-7 (MK-7). Silvia Pisoni will talk about this vital nutrient newly recognized for supporting bone and cardiovascular health, vitamin K2 mechanism, MenaQ7® clinical validation and Gnosis by Lesaffre’s vitamin K2 solutions platforms.
Explore Why Folate (Vitamin B9) and Vitamin K2 Are in the Limelight
Find Out More About Quatrefolic®
Quatrefolic® is the glucosamine salt of (6S)-5-methyltetrahydrofolate and is structurally analogous to the reduced and active form of folic acid.
Developed by Gnosis By Lesaffre, it represents the fourth-generation folate compared to 5-methyltetrahydrofolate calcium salt, guaranteeing improved bioavailability.
